 MINNEAPOLIS, April 27, 2021 PRNewswire -- Bio-Techne Corporation NASDAQ:TECH today announced the expansion of the Advanced Cell Diagnostics ACD, a Bio-Techne brand, RNAscopeTM technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization ISH assay that enables visualization of single-molecule gene expression with single-cell resolution directly in intact cells and tissues. 